Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;181(5):703-706.
doi: 10.1111/bjh.14699. Epub 2017 Apr 25.

Incidence and survival trends in mantle cell lymphoma

Narendranath Epperla  1 , Mehdi Hamadani  1 , Timothy S Fenske  1 , Luciano J Costa  2
Affiliations

Incidence and survival trends in mantle cell lymphoma

Narendranath Epperla et al. Br J Haematol. 2018 Jun.
No abstract available

Keywords: incidence; mantle cell lymphoma; population outcomes; relative survival rate; survival.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Sequencing of Novel Therapies for Mantle Cell Lymphoma.
    Romancik JT, Cohen JB. Romancik JT, et al. Curr Treat Options Oncol. 2021 Nov 23;22(12):118. doi: 10.1007/s11864-021-00907-3. Curr Treat Options Oncol. 2021. PMID: 34812968 Review.
  • Interaction Between Age and Tumor Stage in Survival Outcomes of Patients With Mantle Cell Lymphoma.
    Bangolo A, Amoozgar B, Nagesh VK, McGrath K, Mallipeddi S, Cash S, Sandilya A, Banu R, Martine FR, Gill S, Zhang L, Naeem S, Mallampalli P, Ram A, Papantoniou D, Nareeba S, Baek K, Sharma U, Mondal G, Bano K, Gad M, Rokade PR, Kharat MM, Dodhia A, Goud S, Gavva S, Aduna EG, Siddiqui ZS, Palvia AR, Singh A, Nayak A, Jakkula KP, Jethi A, Thota N, Weissman S. Bangolo A, et al. J Community Hosp Intern Med Perspect. 2025 May 5;15(3):5-14. doi: 10.55729/2000-9666.1480. eCollection 2025. J Community Hosp Intern Med Perspect. 2025. PMID: 40756000 Free PMC article.
  • Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
    Shanmugasundaram K, Goyal S, Switchenko J, Calzada O, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Sawalha Y, Hill BT, Ghosh N, Park SI, Epperla N, Bond DA, Badar T, Blum KA, Hamadani M, Fenske TS, Malecek M, Kahl BS, Martin P, Guo J, Flowers CR, Cohen JB. Shanmugasundaram K, et al. Eur J Haematol. 2021 Sep;107(3):301-310. doi: 10.1111/ejh.13649. Epub 2021 Jun 17. Eur J Haematol. 2021. PMID: 33973276 Free PMC article.
  • Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL).
    Tbakhi B, Reagan PM. Tbakhi B, et al. Ther Adv Hematol. 2022 Feb 26;13:20406207221080738. doi: 10.1177/20406207221080738. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35237395 Free PMC article. Review.
  • Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
    Epperla N, Switchenko J, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Sawalha Y, Hill BT, Ghosh N, Park SI, Bond DA, Hamadani M, Fenske TS, Martin P, Malecek MK, Kahl BS, Flowers CR, Link BK, Kaplan LD, Inwards DJ, Feldman AL, Hsi ED, Maddocks K, Blum KA, Bartlett NL, Cerhan JR, Leonard JP, Habermann TM, Maurer MJ, Cohen JB. Epperla N, et al. Blood Adv. 2023 Jun 13;7(11):2287-2296. doi: 10.1182/bloodadvances.2022009225. Blood Adv. 2023. PMID: 36516079 Free PMC article.
See all "Cited by" articles

LinkOut - more resources